Drug intelligence / Profile preview

Inhibitor Idd 384

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
01

Overview

Inhibitor Idd 384 is an experimental small molecule compound belonging to the class of benzenesulfonamides. Its chemical formula is C19H22N2O5S and it has a molecular weight of approximately 390.5 g/mol[1][2]. The compound has been studied as a discovery agent and is not approved for clinical use in any country[1][3]. It is primarily referenced in research contexts and does not have any known approved indications or completed clinical trials as of now[1].

Other names
2-(2,6-dimethyl-4-(2-(2-methylphenyl)acetamido)benzenesulfonamido)acetic acid2-{2,6-dimethyl-4-[2-(2-methylphenyl)acetamido]benzenesulfonamido}acetic acid[2,6-dimethyl-4-(2-o-tolyl-acetylamino)-benzenesulfonyl]-glycine2-(2,6-dimethyl-4-(2-o-tolylacetamido)phenylsulfonamido)acetic acidN-[(2,6-dimethyl-4-{[(2-methylphenyl)acetyl]amino}phenyl)sulfonyl]glycine

Beyond the preview

Go deeper on Inhibitor Idd 384.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor Idd 384.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call